Skeletal Muscle Tissue Engineering is a multidisciplinary field focused on developing artificial skeletal muscle tissues for therapeutic applications, regenerative medicine, and studying muscle physiology in vitro. Researchers aim to create functional muscle constructs that mimic the structure and function of native skeletal muscle tissue. The process involves combining cells, biomaterial scaffolds, and signaling factors to encourage tissue formation. Cells used in skeletal muscle tissue engineering often include myoblasts, satellite cells, or pluripotent stem cells, which are cultured on biocompatible scaffolds that provide structural support and mimic the extracellular matrix of native muscle tissue. These scaffolds guide cell alignment and organization, crucial for the development of functional muscle fibers. Various techniques are employed to stimulate cell differentiation and maturation within engineered muscle tissues. Electrical and mechanical stimulation, along with biochemical cues, help promote the formation of contractile muscle fibers. Additionally, the incorporation of vascularization strategies is crucial to ensure nutrient and oxygen supply to the engineered tissue. The ultimate goal of skeletal muscle tissue engineering is to create viable muscle grafts that can be used for transplantation or repair in patients with muscle injuries, defects, or degenerative disorders. This technology holds promise for addressing conditions such as volumetric muscle loss or muscular dystrophy.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy